Trial Financial Management White Papers & Case Studies

  1. Device Integration: Revolutionizing Clinical Trials And Real World Healthcare
    6/25/2015

    To begin with – a bold statement: it is without doubt that the future success of the pharmaceutical industry relies heavily on increasingly intelligent solutions to increase both the cost-effectiveness of clinical trials, and reduce the burden of healthcare cost throughout the world. The advance of technology can now be observed in both the clinical and healthcare arenas, however, this was not always the case

  2. Advances In Electronic Data Capture Of Medical Data
    5/7/2013

    Electronic Data Capture (EDC) refers to the collection of medical data for patients enrolled in clinical trials. The most common mechanism is for staff at the investigative site to enter the data into a web-based interface, and for staff at the sponsor company to monitor the data using the same interface but with different security permissions. By Keith Howells

  3. New Molecular Entities (NMEs) The Path Of Resistance
    5/3/2013

    On a global scale, the number of new molecular entities (NMEs) in development—and, more importantly, the number being approved by regulatory authorities— has dropped significantly in recent years.

  4. Moving Towards An Electronic Environment In Clinical Trials
    5/3/2013

    With each passing year, clinical trials are becoming increasingly global. The business of product development is moving away from the traditional model in which studies are conducted primarily in the US – in fact, recent estimates indicate that within the next three years, up to 65 per cent of studies under FDA regulation will be conducted outside the US. A review of a US government clinical trials registry and of 300 published reports in major medical journals revealed that one third (157 of 509) of Phase III trials were being conducted entirely outside the US, with over half the study sites (13,521 of 24,206) used in these trials located overseas, many in eastern Europe and Asia.

  5. Merge CTMS For Investigators - Enterprise Datasheet
    4/17/2013

    You want a clinical trial management system (CTMS) that is simple enough for all stakeholders to use and that delivers results.

  6. Merge CTMS For Investigators Features And Capabilities
    4/17/2013

    Merge CTMS for Investigators offers groundbreaking ease-of-use, power, and flexibility, helping you organize and centralize your clinical research. Scalable, secure, and backed by the most comprehensive customer support program in the industry, Merge CTMS is the site success solution.

  7. Merge CTMS For Investigators - Independent Research Datasheet
    4/17/2013

    You are constantly facing increased competition for the best studies, mountains of papers and spreadsheets, vast array of complex sponsor contracts to track, and pressure to watch the bottom line.

  8. Merge eClinical OS™ Brochure
    3/28/2013

    Merge eClinical OS™, our flagship product, is a truly unified platform designed to help clients manage and run studies faster and more cost effectively.

  9. EDC And Getting Ready For Migration
    3/21/2013

    As the biopharmaceutical industry continues its transition to electronic data capture (EDC), the days of paper-based clinical trials are numbered.

  10. CFS Clinical Helps Top 20 Pharma Improve Investigator Payment And Budget Management While Addressing Sunshine & FMV Compliance
    3/19/2013

    Like its peers of all sizes operating in the United States, this Top 20 Pharma has faced the challenge of anticipating and addressing the Physician Payment Sunshine Provision (PPSP) within the Patient Protection and Affordable Care Act (PPACA) of 2009. Presented By Jim DiCesare, VP and General Manager, Contract and Regulatory Services